Post transplant lymphoproliferative disease: detection of tumor by Tc99m sestaMIBI and treatment with rituximab.
Paydas
S
S
Yapar
Z
Z
Ergin
M
M
Guney
I B
IB
Disel
U
U
Yavuz
S
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D000069283:Rituximab; D017256:Technetium Tc 99m Sestamibi
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D017256:Technetium Tc 99m Sestamibi